Table 1.
Structural Change |
Yield |
Agonist Activity |
|||
---|---|---|---|---|---|
Protein | Residues 35-55 with deletions or replacements underlined | Monomer yield | Monomer percentage | ED50 (nM) | Fold decrease |
WT hPRL | EMFSEFDKRYTHGRGFITKAI | 15.4 mg | 90% | 0.23 | 1 |
Δ41-52 hPRL | EMFSEFKAI | 9.4 mg | 42% | 702.42 | 3041 |
G2-ΔhPRL | EMFSEFGGKAI | 2.7 mg | 39% | 5.25 | 23 |
G3-ΔhPRL | EMFSEFGGGKAI | 7.9 mg | 40% | 18.91 | 82 |
G4-ΔhPRL | EMFSEFGGGGKAI | 13.5 mg | 57% | 1277.16 | 5312 |
G5-ΔhPRL | EMFSEFGGGGGKAI | 11.4 mg | 67% | 1.36 | 6 |
A2-ΔhPRL | EMFSEFAAKAI | 6.2 mg | 34% | 163.38 | 707 |
SPGG-ΔhPRL | EMFSEFSPGGKAI | 8.7 mg | 49% | 0.44 | 2 |
DGFIT-ΔhPRL | EMFSEFDGFITKAI | 17.5 mg | 52% | 45.94 | 207 |
DIT-ΔhPRL | EMFSEFDITKAI | 13.4 mg | 70% | 47.93 | 199 |
G129R hPRL | ------- | 18.3 mg | 90% | 5.99 | 26 |